Welcome to our dedicated page for Lifemd news (Ticker: LFMDP), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.
LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (symbol: LFMDP) is backed by a company that offers a comprehensive telemedicine solution connecting physicians, medical providers, pharmacists, and patients worldwide. Their platform is HIPAA-compliant and encrypted, allowing for secure interactions and management of medical conditions. In addition to telehealth services, they also provide mobile diagnostic telehealth equipment and sell nutritional supplements and over-the-counter products. With a focus on virtual primary care, LifeMD is committed to providing accessible, high-quality healthcare services.
Rhea-AI Summary
LifeMD, Inc. (LFMD) expects revenue between $195 and $205 million, a 31% to 38% increase over 2023 guidance. Adjusted EBITDA is expected to be between $18 and $22 million, a 71% to 110% increase over the midpoint of 2023 guidance. The company also anticipates positive full-year free cash flow with estimated year-end 2023 cash exceeding $30 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) authorizes a cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP), payable on January 15, 2024, to holders of record on January 5, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
LifeMD, Inc.TM (Nasdaq: LFMD) announced a strategic alliance with Medifast (NYSE: MED) to integrate LifeMD’s telehealth platform and GLP-1 offering for medically qualified patients with OPTAVIA Coach-guided, healthy lifestyle solution. Medifast has invested $20 million, including a $10 million payment in support of the collaboration and a $10 million purchase of LifeMD common stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
Rhea-AI Summary
LifeMD, Inc. (LFMD) to Participate in RWJBarnabas Health Telehealth Symposium, Showcasing the Role of Telehealth in Quality Patient Care
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) to participate in upcoming investor conferences and panel discussions. CEO Justin Schreiber to discuss GLP-1s at Cantor Fitzgerald panel and digital health at BTIG forum. Sidoti's Small-Cap Virtual Conference to feature corporate overview and one-on-one investor meetings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) reported a 23% year-over-year revenue increase to $38.6 million, with record revenues for telehealth and WorkSimpli. Adjusted EPS was $0.08 per share, compared to a loss of $0.03 in the previous year. Weight Management revenue more than quadrupled, and telehealth subscribers grew 22% to a record 207,000 patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
Rhea-AI Summary
LifeMD (NASDAQ: LFMD) achieved 855% revenue growth, ranking 166 on the Deloitte Technology Fast 500™. The growth is attributed to the differentiated, end-to-end care platform and affiliated medical group, supporting offerings like the LifeMD Weight Management Program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
-
Rhea-AI Summary
LifeMD, Inc. will report financial results for Q3 2023 on November 8th and host a conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
-
Rhea-AI Summary
Joint research study by Particle Health and LifeMD demonstrates that Particle's platform can help healthcare providers contextualize patient data and identify eligibility for GLP-1 treatment, potentially saving physicians time and improving patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) to participate in investor conferences in October.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
FAQ
What is the current stock price of Lifemd (LFMDP)?
The current stock price of Lifemd (LFMDP) is $22.315 as of February 21, 2025.
What does LifeMD, Inc. offer?
LifeMD offers a comprehensive telemedicine solution connecting physicians, medical providers, pharmacists, and patients worldwide.
Is LifeMD's platform secure?
Yes, LifeMD's platform is HIPAA-compliant and all interactions are encrypted for security.
What products does LifeMD sell?
In addition to telehealth services, LifeMD sells nutritional supplements and over-the-counter products.
What is the focus of LifeMD's services?
LifeMD is focused on providing virtual primary care to make high-quality healthcare accessible for all.
How does LifeMD contribute to the healthcare industry?
LifeMD's telemedicine platform and services aim to improve patient outcomes and provide more convenient access to healthcare.
Lifemd, Inc.
Nasdaq:LFMDP
LFMDP Rankings
LFMDP Stock Data
1.40M
Health Information Services
Services-offices & Clinics of Doctors of Medicine
United States
NEW YORK